Cargando…
Impact of age on morbidity and outcome of concurrent radiochemotherapy in high-risk FIGO stage I to IVA carcinoma of the uterine cervix following laparoscopic surgery
PURPOSE: To evaluate the impact of age on treatment-related acute morbidity, on modifications of drug doses and radiotherapy and on disease-free and overall survival in non-elderly and elderly with high-risk cervical cancer treated with concurrent radiochemotherapy following laparoscopic surgery. ME...
Autores principales: | Laurentius, Thea, Altendorf-Hofmann, Annelore, Camara, Oumar, Runnebaum, Ingo B., Wendt, Thomas G. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3036825/ https://www.ncbi.nlm.nih.gov/pubmed/20473526 http://dx.doi.org/10.1007/s00432-010-0903-y |
Ejemplares similares
-
Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009) -
Prognostic Significance of DNA Cytometry in Carcinoma of the Uterine Cervix FIGO Stage IB and II
por: Grote, Hans Jürgen, et al.
Publicado: (2001) -
Comparison of concurrent chemoradiation therapy with weekly cisplatin versus monthly fluorouracil plus cisplatin in FIGO stage IIB-IVA cervical cancer
por: Kong, Tae Wook, et al.
Publicado: (2012) -
Efficacy and safety of nedaplatin-based concurrent chemoradiotherapy for FIGO Stage IB2–IVA cervical cancer and its clinical prognostic factors
por: Fujiwara, Masateru, et al.
Publicado: (2015) -
Concurrent radiochemotherapy in advanced hypopharyngeal cancer
por: Krstevska, Valentina, et al.
Publicado: (2010)